| 1 |
Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study |
|
| | Suthinee Rutnin, Poonkiat Suchonwanit, Chaninan Kositkuljorn, Cherrin Pomsoong, Sira Korpaisarn, Jiraporn Arunakul, Teerapong Rattananukrom | | | Transgender Health. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Insights into male androgenetic alopecia using comparative transcriptome profiling: hypoxia-inducible factor-1 and Wnt/ß-catenin signalling pathways |
|
| | Qingmei Liu, Yulong Tang, Yan Huang, Ji’an Wang, Kai Yang, Yuting Zhang, Weilin Pu, Jing Liu, Xiangguang Shi, Yanyun Ma, Chunya Ni, Yue Zhang, Yifei Zhu, Haiyang Li, Jiucun Wang, Jinran Lin, Wenyu Wu | | | British Journal of Dermatology. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
The role of prostaglandins in androgenetic alopecia |
|
| | Eleni Chovarda, Eleni Sotiriou, Elizabeth Lazaridou, Efstratios Vakirlis, Demetrios Ioannides | | | International Journal of Dermatology. 2021; 60(6): 730 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation |
|
| | Soheir Ghonemy, Abeer Alarawi, Hagar Bessar | | | Journal of Dermatological Treatment. 2021; 32(2): 236 | | | [Pubmed] [Google Scholar] [DOI] | |
|
